HB 7117 — Medical Use of Marijuana

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 A bill to be entitled An act relating to the medical use of marijuana;

381.986;381.986, F.S.;

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 laboratory from having an economic interest in or financial relationship with a medical marijuana treatment center;

providing an appropriation;

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 likely outweigh the potential health risks for the patient, and such determination must be documented in the patient's medical record.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 registry in an electronic manner determined by the department, and:

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 minimum, information related to:

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 marijuana, more than six 35-day supply limits of edibles, or more than six 35-day supply limits of marijuana in a form for smoking.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 2.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 not contract for services directly related to the cultivation, processing, and dispensing of marijuana or marijuana delivery devices, except that a medical marijuana treatment center licensed pursuant to subparagraph (a)1.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 requirements of this section.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 individual or entity who directly or indirectly owns, controls, or holds with power to vote 5 percent or more of the voting shares of a medical marijuana treatment center, may not acquire direct or indirect ownership or control of any voting shares or other form of ownership of any other medical marijuana treatment center.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 b.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 color additives.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 with hydrocarbon solvents or other solvents or gases exhibiting potential toxicity to humans.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 tested for and the maximum levels of each contaminant which are safe for human consumption.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 perform audits on the medical marijuana treatment center's standard operating procedures, testing records, and samples and provide the results to the department to confirm that the marijuana or low-THC cannabis meets the requirements of this section and that the marijuana or low-THC cannabis is safe for human consumption.

(I) The marijuana or low-THC cannabis meets the requirements of subparagraph 12 sub-subparagraph d.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 marijuana originates and the date dispensed.

In addition to the packaging and labeling requirements specified in subparagraphs 13.12., 13., and 14.

and 14.

and 12., Page 16 of 23 CODING:

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 and 12., marijuana in a form for smoking must be packaged in a sealed receptacle with a legible and prominent warning to keep away from children and a warning that states marijuana smoke contains carcinogens and may negatively affect health.

Such receptacles for marijuana in a form for smoking must be plain, opaque, and white without depictions of the product or images other than the medical marijuana treatment center's department-approveddepartment- approved logo and the marijuana universal symbol.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 inspected pursuant to federal food safety laws.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 device enter into the medical marijuana use registry his or her name or unique employee identifier.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 i.h.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 tests conducted by a certified laboratory.— (12) A certified medical marijuana testing laboratory and its officers, directors, and employees may not have a direct or indirect economic interest in, or financial relationship with, a medical marijuana treatment center.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 nonemergency rulemaking procedures of the Administrative Procedures Act to replace the rule that has become void.

hb7117-00hb7117-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 7117 2019 publishing a notice of rule development in the Florida Administrative Register.

For the 2019-2020 fiscal year, the sum of $350,000 in nonrecurring funds from the Grants and Donations Trust Fund is appropriated to the Department of Health for the purpose of implementing this act.

Section 5.

hb7117-00hb7117-01-c1